REGINA BROOKS-HALL: Open Payments
NPI 1417049404 · EDGEWOOD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$723 in 45 payments from 11 companies in 2025. Trend: 2023 $338 · 2024 $317 · 2025 $723
Food & beverage: $723
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $189 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $135 |
| E.R. Squibb & Sons, L.L.C. | 5 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $86 |
| PFIZER INC. | 4 | $68 |
| Novo Nordisk Inc | 2 | $39 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| SIOUX SURGICAL INC | 2 | $29 |
| Octapharma USA, Inc. | 1 | $26 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
Products named: LEQVIO, Kerendia, JARDIANCE, CAMZYOS, ELIQUIS, ONPATTRO, VYNDAQEL, FIBRYGA.
Industry payments across KY — which companies pay providers there.
